DOI QR코드

DOI QR Code

Optimal Ratio of Wnt3a Expression in Human Mesenchymal Stem Cells Promotes Axonal Regeneration in Spinal Cord Injured Rat Model

  • Yoon, Hyung Ho (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Hyang Ju (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine) ;
  • Min, Joongkee (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jeong Hoon (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Jin Hoon (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Ji Hyun (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Kim, Seong Who (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine) ;
  • Lee, Heuiran (Department of Microbiology, University of Ulsan College of Medicine) ;
  • Jeon, Sang Ryong (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2021.01.04
  • 심사 : 2021.04.07
  • 발행 : 2021.09.01

초록

Objective : Through our previous clinical trials, the demonstrated therapeutic effects of MSC in chronic spinal cord injury (SCI) were found to be not sufficient. Therefore, the need to develop stem cell agent with enhanced efficacy is increased. We transplanted enhanced Wnt3-asecreting human mesenchymal stem cells (hMSC) into injured spines at 6 weeks after SCI to improve axonal regeneration in a rat model of chronic SCI. We hypothesized that enhanced Wnt3a protein expression could augment neuro-regeneration after SCI. Methods : Thirty-six Sprague-Dawley rats were injured using an Infinite Horizon (IH) impactor at the T9-10 vertebrae and separated into five groups : 1) phosphate-buffered saline injection (injury only group, n=7); 2) hMSC transplantation (MSC, n=7); 3) hMSC transfected with pLenti vector (without Wnt3a gene) transplantation (pLenti-MSC, n=7); 4) hMSC transfected with Wnt3a gene transplantation (Wnt3a-MSC, n=7); and 5) hMSC transfected with enhanced Wnt3a gene (1.7 fold Wnt3a mRNA expression) transplantation (1.7 Wnt3a-MSC, n=8). Six weeks after SCI, each 5×105 cells/15 µL at 2 points were injected using stereotactic and microsyringe pump. To evaluate functional recovery from SCI, rats underwent Basso-Beattie-Bresnahan (BBB) locomotor test on the first, second, and third days post-injury and then weekly for 14 weeks. Axonal regeneration was assessed using growth-associated protein 43 (GAP43), microtubule-associated protein 2 (MAP2), and neurofilament (NF) immunostaining. Results : Fourteen weeks after injury (8 weeks after transplantation), BBB score of the 1.7 Wnt3a-MSC group (15.0±0.28) was significantly higher than that of the injury only (10.0±0.48), MSC (12.57±0.48), pLenti-MSC (12.42±0.48), and Wnt3a-MSC (13.71±0.61) groups (p<0.05). Immunostaining revealed increased expression of axonal regeneration markers GAP43, MAP2, and NF in the Wnt3a-MSC and 1.7 Wnt3a-MSC groups. Conclusion : Our results showed that enhanced gene expression of Wnt3a in hMSC can potentiate axonal regeneration and improve functional recovery in a rat model of chronic SCI.

키워드

과제정보

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI16C2188), and funded by a grant (18-176 and 19-176) from the Asan Institute for Life Science, Seoul, Korea.

참고문헌

  1. Basso DM, Beattie MS, Bresnahan JC : A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12 : 1-21, 1995 https://doi.org/10.1089/neu.1995.12.1
  2. Blits B, Kitay BM, Farahvar A, Caperton CV, Dietrich WD, Bunge MB : Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 23 : 313-324, 2005
  3. Boyce VS, Mendell LM : Neurotrophic factors in spinal cord injury. Handb Exp Pharmacol 220 : 443-460, 2014 https://doi.org/10.1007/978-3-642-45106-5_16
  4. Chao MV : Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4 : 299-309, 2003 https://doi.org/10.1038/nrn1078
  5. Dinsmore J, Ratliff J, Deacon T, Pakzaban P, Jacoby D, Galpern W, et al. : Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant 5 : 131-143 1996 https://doi.org/10.1177/096368979600500205
  6. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, et al. : Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45 : 190-205, 2007 https://doi.org/10.1038/sj.sc.3102007
  7. Hirabayashi Y, Itoh Y, Tabata H, Nakajima K, Akiyama T, Masuyama N, et al. : The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development 131 : 2791-2801, 2004 https://doi.org/10.1242/dev.01165
  8. Huelsken J, Behrens J : The Wnt signalling pathway. J Cell Sci 115 : 3977-3978, 2002 https://doi.org/10.1242/jcs.00089
  9. Jeong SK, Choi I, Jeon SR : Current status and future strategies to treat spinal cord injury with adult stem cells. J Korean Neurosurg Soc 63 : 153-162, 2020 https://doi.org/10.3340/jkns.2019.0146
  10. Kutikov AB, Moore SW, Layer RT, Podell PE, Sridhar N, Santamaria AJ, ed al. : Method and apparatus for the automated delivery of continuous neural stem cell trails into the spinal cord of small and large animals. Neurosurgery 85 : 560-573, 2019 https://doi.org/10.1093/neuros/nyy379
  11. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, et al. : Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5 : 1410-1412, 1999 https://doi.org/10.1038/70986
  12. Mehra A, Lee KH, Hatzimanikatis V : Insights into the relation between mRNA and protein expression patterns: I. Theoretical considerations. Biotechnol Bioeng 84 : 822-833, 2003 https://doi.org/10.1002/bit.10860
  13. Miyashita T, Koda M, Kitajo K, Yamazaki M, Takahashi K, Kikuchi A, et al. : Wnt-Ryk signaling mediates axon growth inhibition and limits functional recovery after spinal cord injury. J Neurotrauma 26 : 955-964, 2009 https://doi.org/10.1089/neu.2008.0776
  14. Mukhamedshina YO, Akhmetzyanova ER, Kostennikov AA, Zakirova EY, Galieva LR, Garanina EE, et al. : Adipose-derived mesenchymal stem cell application combined with fibrin matrix promotes structural and functional recovery following spinal cord injury in rats. Front Pharmacol 9 : 343, 2018 https://doi.org/10.3389/fphar.2018.00343
  15. Nakano N, Nakai Y, Seo TB, Homma T, Yamada Y, Ohta M, et al. : Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats. PLoS One 8 : e73494, 2013 https://doi.org/10.1371/journal.pone.0073494
  16. Oh SK, Choi KH, Yoo JY, Kim DY, Kim SJ, Jeon SR : A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery 78 : 436-447; discussion 447, 2016 https://doi.org/10.1227/NEU.0000000000001056
  17. Ohta M, Suzuki Y, Noda T, Ejiri Y, Dezawa M, Kataoka K, et al. : Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 187 : 266-278, 2004 https://doi.org/10.1016/j.expneurol.2004.01.021
  18. Onishi K, Hollis E, Zou Y : Axon guidance and injury-lessons from Wnts and Wnt signaling. Curr Opin Neurobiol : 232-240, 2014
  19. Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, et al. : Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 1343 : 226-235, 2010 https://doi.org/10.1016/j.brainres.2010.05.011
  20. Park JH, Kim DY, Sung IY, Choi GH, Jeon MH, Kim KK, et al. : Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 70 : 1238-1247; discussion 1247, 2012 https://doi.org/10.1227/NEU.0b013e31824387f9
  21. Park JH, Min J, Baek SR, Kim SW, Kwon IK, Jeon SR : Enhanced neuroregenerative effects by scaffold for the treatment of a rat spinal cord injury with Wnt3a-secreting fibroblasts. Acta Neurochir (Wien) 155 : 809-816, 2013 https://doi.org/10.1007/s00701-013-1663-7
  22. Parr BA, Shea MJ, Vassileva G, McMahon AP : Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 119 : 247-261, 1993 https://doi.org/10.1242/dev.119.1.247
  23. Patapoutian A, Reichardt LF : Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 10 : 392-399, 2000 https://doi.org/10.1016/S0959-4388(00)00100-8
  24. Samdani AF, Paul C, Betz RR, Fischer I, Neuhuber B : Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study. Spine (Phila Pa 1976) 34 : 2605-2612, 2009 https://doi.org/10.1097/BRS.0b013e3181bdca87
  25. Seo DK, Kim JH, Min J, Yoon HH, Shin ES, Kim SW, et al. : Enhanced axonal regeneration by transplanted Wnt3a-secreting human mesenchymal stem cells in a rat model of spinal cord injury. Acta Neurochir (Wien) 159 : 947-957, 2017 https://doi.org/10.1007/s00701-017-3097-0
  26. Suh HI, Min J, Choi KH, Kim SW, Kim KS, Jeon SR : Axonal regeneration effects of Wnt3a-secreting fibroblast transplantation in spinal cordinjured rats. Acta Neurochir (Wien) 153 : 1003-1010, 2011 https://doi.org/10.1007/s00701-011-0945-1
  27. Verma R, Virdi JK, Singh N, Jaggi AS : Animals models of spinal cord contusion injury. Korean J Pain 32 : 12-21, 2019 https://doi.org/10.3344/kjp.2019.32.1.12
  28. Zou Y : Wnt signaling in axon guidance. Trends Neurosci 27 : 528-532, 2004 https://doi.org/10.1016/j.tins.2004.06.015